Somalia vs Timor-Leste: Access to anti-retroviral drugs, male
Somalia
63.0%
in 2024
Timor-Leste
62.0%
in 2024
Somalia rank
92nd
Timor-Leste rank
94th
Access to anti-retroviral drugs, male over time
- Somalia
- Timor-Leste
How they compare
Somalia currently reports 63.0% against 62.0% in Timor-Leste, a difference of 1.0%.
The two have swapped places 3 times across 22 shared years of data; in 2000 it was Timor-Leste ahead.
Somalia ranks 92nd and Timor-Leste ranks 94th of 141 countries.
Across the 3 decades both report, Somalia averaged higher in 2 and Timor-Leste in 1.
Head to head by decade
| Decade | Somalia | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.7% | 0.6% | 1.1% | Somalia |
| 2010s | 23.8% | 13.9% | 9.9% | Somalia |
| 2020s | 51.0% | 53.4% | 2.4% | Timor-Leste |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Somalia or Timor-Leste?
- Somalia, at 63.0% against 62.0% in Timor-Leste as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Somalia and Timor-Leste?
- 1.0%, with Somalia ahead.
- How many years of comparable data are there for Somalia and Timor-Leste?
- 22 years are reported by both, from 2000 to 2024.
- How do Somalia and Timor-Leste rank globally for access to anti-retroviral drugs, male?
- Somalia ranks 92nd and Timor-Leste ranks 94th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.